Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer
Jeffrey Schlom(National Institutes of Health), John M. Hamilton(National Cancer Institute), Scott I. Abrams(Roswell Park Comprehensive Cancer Center), Dennis Panicali(Fox Chase Cancer Center), Kwong Y. Tsang(Center for Biologics Evaluation and Research), Judy Kantor(National Cancer Institute)
Cited by 39
Related Papers
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
|Cell|1991|1.6k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|975
High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors
|Journal of Virology|1995|513
Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.
|Proceedings of the National Academy of Sciences|1982|503
Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine
|JNCI Journal of the National Cancer Institute|1995|498